<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00680862</url>
  </required_header>
  <id_info>
    <org_study_id>SHP 08-158</org_study_id>
    <nct_id>NCT00680862</nct_id>
  </id_info>
  <brief_title>Qualitative Assessment of Implementing Routine Rapid HIV Testing</brief_title>
  <official_title>Qualitative Assessment of Implementing Routine Rapid HIV Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Qualitative assessment of implementing routine HIV rapid testing in primary care clinics
      within VA
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      During the past three decades, human immunodeficiency virus (HIV) infection and acquired
      immunodeficiency syndrome (AIDS) have caused extensive illness and death in the United
      States. Since the advent of the HIV epidemic, the VA healthcare system has been significantly
      impacted. Veterans are at much higher HIV risk than the general population. In addition, a
      significant proportion of VA patients are members of minority groups, and are homeless, both
      patient categories which have also been linked to high HIV prevalence. Because the VA is the
      largest provider of HIV treatment in the US, it is imperative that researchers develop
      innovative methods to 1) identify HIV-positive individuals, 2) provide them with the
      knowledge of their HIV-positive status; 3) do so early enough in the disease so that patients
      can be placed into care, so that antiretroviral therapies can be effective, and the HIV
      epidemic can be slowed and reversed.

      Current HIV testing methods have been highly ineffective in this regard, due in large measure
      to the method itself. Conventional HIV testing requires both a blood draw and laboratory
      analysis, requiring a patient to schedule a future visit to receive results. Consequently, a
      significant number of people simply do not return for their test results. Current HIV
      prevalence figures bear this out. The Centers for Disease Control and Prevention (CDC)
      estimates that of the 1.2 million HIV infected persons in the US, as many as 1/3 are unaware
      of their infection. Indeed, the CDC now recommends routine HIV testing for all Americans.
      This recommendation was predicated on the evidence that moving from a risk-based, to a
      routine testing model is one of the most effective ways to significantly increase testing
      rates. As better HIV identification systems begin to spread through the VHA, the VHA must
      determine the proper place for broader routine HIV rapid testing programs in their delivery
      systems. Demonstrating effectiveness is only the first step. To make policy recommendations,
      we must better understand the challenges of implementing a testing system that would apply to
      all, not just at-risk patients.

      The move toward routine HIV testing, combined with a novel diagnostic tool (rapid testing)
      although highly effective, provides many implementation challenges. For example, what are the
      unintended adverse consequences in implementing NRT? What are the barriers and facilitators
      to implementation? How important are local nursing and physician champions and opinion
      leaders? These issues are of paramount importance in reaching an evidence-based consensus as
      to what a 'best practices' approach could look like within a large, decentralized healthcare
      organization like VA.

      Objectives:

      The specific aims of this project then, are:

        1. To develop generalized qualitative methods and instruments which can be used to evaluate
           VA HIV rapid testing implementation efforts;

        2. To employ these developed instruments to qualitatively document the implementation of
           our previously successful NRT strategy for spreading NRT to VA primary/urgent care
           practice at our downtown Los Angeles Outpatient Clinic (OPC);

        3. To explore and document barriers, facilitators, and unintended consequences of
           implementing our NRT model of HIV testing at LAOPC.

      Methods:

      We used qualitative methods to conduct formative and process evaluations which allowed us to
      fully assess our research objective, which were:

      A thorough examination, exploration and description of the barriers and facilitators to
      implementing NRT at the Los Angeles Outpatient Clinic (OPC).

      Status:

      project objectives completed; manuscript being developed
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Completed the Survey</measure>
    <time_frame>6 months</time_frame>
    <description>survey responses from participants on thoughts pertaining to implementation of HIV rapid testing</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>VA employees</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        key informant VA employees
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - VA employees of LA OPC who are involved in HIV care and/or policy

        Exclusion Criteria:

        - n/a
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henry Anaya, PhD MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Greater Los Angeles Healthcare System, West Los Angeles, CA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Greater Los Angeles Healthcare System, West Los Angeles, CA</name>
      <address>
        <city>West Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Anaya HD, Bokhour B, Feld J, Golden JF, Asch SM, Knapp H. Implementation of routine rapid HIV testing within the U.S. Department of Veterans Affairs Healthcare System. J Healthc Qual. 2012 Sep-Oct;34(5):7-14. doi: 10.1111/j.1945-1474.2011.00151.x. Epub 2011 May 25.</citation>
    <PMID>22060061</PMID>
  </results_reference>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2008</study_first_submitted>
  <study_first_submitted_qc>May 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2008</study_first_posted>
  <results_first_submitted>August 27, 2014</results_first_submitted>
  <results_first_submitted_qc>September 26, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 29, 2014</results_first_posted>
  <last_update_submitted>September 26, 2014</last_update_submitted>
  <last_update_submitted_qc>September 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group 1</title>
          <description>VA employees</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>VA employees</population>
      <group_list>
        <group group_id="B1">
          <title>Group 1</title>
          <description>VA employees</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Completed the Survey</title>
        <description>survey responses from participants on thoughts pertaining to implementation of HIV rapid testing</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>VA employees</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Completed the Survey</title>
          <description>survey responses from participants on thoughts pertaining to implementation of HIV rapid testing</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Serious and other [non-serious] adverse events were not collected or assessed as part of the study</desc>
      <group_list>
        <group group_id="E1">
          <title>Group 1</title>
          <description>VA employees</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Henry Anaya</name_or_title>
      <organization>VHA</organization>
      <phone>310-478-3711 ext 48488</phone>
      <email>henry.anaya@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

